Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

II. EFFECT OF TRANSFUSED BLOOD AND OF STREPTOCOCCIC ANTISERUM ON THE CONCENTRATIONS OF ANTIFIBRINOLYSIN AND ANTISTREPTOLYSIN IN THE BLOOD OF THE RECIPIENTS

II. EFFECT OF TRANSFUSED BLOOD AND OF STREPTOCOCCIC ANTISERUM ON THE CONCENTRATIONS OF... Blood transfusions are employed almost universally in the treatment of patients with severe hemolytic streptococcic infections. For this purpose, blood of three different types has come into general use, i. e., blood from nonimmune persons, from convalescents and from donors prepared by vaccination. Numerous clinical reports justify the use of blood from nonimmune donors, especially when the patient is anemic or suffering from a prolonged illness. Of particular interest in relation to the present study are the investigations of erysipelas in childhood by Schaffer and Rothman1 and the review of the therapeutic value of transfusions in scarlet fever by Look.2 These authors support the generally accepted opinion that blood from normal, healthy donors is of value in these infections. The literature of the past forty years contains a large number of reports on the use of blood from convalescent patients in the treatment of patients with scarlet fever. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American journal of diseases of children American Medical Association

II. EFFECT OF TRANSFUSED BLOOD AND OF STREPTOCOCCIC ANTISERUM ON THE CONCENTRATIONS OF ANTIFIBRINOLYSIN AND ANTISTREPTOLYSIN IN THE BLOOD OF THE RECIPIENTS

Download PDF
8 pages

Loading next page...
 
/lp/american-medical-association/ii-effect-of-transfused-blood-and-of-streptococcic-antiserum-on-the-2q53MQEEVD

References (6)

Publisher
American Medical Association
Copyright
Copyright © 1935 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0096-8994
eISSN
1538-3628
DOI
10.1001/archpedi.1935.01970060034003
Publisher site
See Article on Publisher Site

Abstract

Blood transfusions are employed almost universally in the treatment of patients with severe hemolytic streptococcic infections. For this purpose, blood of three different types has come into general use, i. e., blood from nonimmune persons, from convalescents and from donors prepared by vaccination. Numerous clinical reports justify the use of blood from nonimmune donors, especially when the patient is anemic or suffering from a prolonged illness. Of particular interest in relation to the present study are the investigations of erysipelas in childhood by Schaffer and Rothman1 and the review of the therapeutic value of transfusions in scarlet fever by Look.2 These authors support the generally accepted opinion that blood from normal, healthy donors is of value in these infections. The literature of the past forty years contains a large number of reports on the use of blood from convalescent patients in the treatment of patients with scarlet fever.

Journal

American journal of diseases of children – American Medical Association

Published: Jun 1, 1935

There are no references for this article.